Inno-Gene will move to WSE, may be acquired

Poland's biotechnology company Inno-Gene will submit its prospectus in H2 of 2015 in order to move from the NewConnect alternative market to the Warsaw Stock Exchange main trading floor, ISBnews agency informed. "The company is willing to move its shares from the NewConnect market to the main trading floor of the WSE. We want to submit the prospectus in the second half of this year. Simultaneously, we have been in talks with entities interested in acquiring our firm. At this moment, the shareholders include investment funds, customers of PZU Asset Management, among others and Moonrock Enterprose," said Cezary Ziarkowski, a board member. Inno-Gene has been supporting and commercializing innovative biotechnology projects, for instance it is going to offer NIPT - Non-Invasive Prenatal Testing since March.